Six Months of Treatment with Risperidone May Be Associated with Nonsignificant Abnormalities of Liver Function Tests in Children and Adolescents: A Longitudinal, Observational Study from Turkey

Erdogan, Ayten; Karaman, Mehmet; Ozdemir, ESRA; Yurteri, Nihal; Tufan, Ali; Kurcer, Mehmet

doi:10.1089/cap.2009.0113

Six Months of Treatment with Risperidone May Be Associated with Nonsignificant Abnormalities of Liver Function Tests in Children and Adolescents: A Longitudinal, Observational Study from Turkey

Atıf İçin Kopyala

Erdogan A., Karaman M. G., Ozdemir E., Yurteri N., Tufan A. E., Kurcer M. A.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, cilt.20, sa.5, ss.407-413, 2010 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 20 Sayı: 5
Basım Tarihi: 2010
Doi Numarası: 10.1089/cap.2009.0113
Dergi Adı: JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.407-413
Erciyes Üniversitesi Adresli: Hayır

Özet

Objective: Risperidone is a promising agent for the treatment of schizophrenia, Tourette's disorder, mood disorders, and disruptive behavior disorders in young populations. However, adverse effects of risperidone may take a long time to emerge. The objective of this study was to investigate the changes in the liver function tests (LFTs) associated with more than 6 months of risperidone treatment in children and adolescents.